Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,234.6
-19.4 (-0.60%)

 

  • STI Straits Times Index
    3,234.6
    -19.4 (-0.60%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.4
    -3.5 (-0.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,909.1
    -431.9 (-1.52%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,976.5
    -84.2 (-2.75%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,795.4
    -235.9 (-0.98%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,249.2
    15.8 (0.25%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,246.1
    -21.1 (-0.93%)
    Index delayed 20 minutes
  • XAO XAO
    7,199.0
    -50.0 (-0.69%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,734.1M
  • Value: 1,390.5M
  • Rise: 93
  • Fall: 228
  • Unch: 497

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Reenova Investment^0.003+0.001
Medtecs Intl0.105+0.007
Ntegrator Intl0.015-
Golden Agri-Res0.225-0.005
Rex Intl0.174-0.014
AusGroup^0.039-0.005
YZJ Shipbldg SGD1.060-0.030
OEL0.024-0.005
Singtel3.340+0.060
Jiutian Chemical0.021-0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,383.8 +13.0
HSI 27,909.1 -431.9
HSCEI 10,952.2 -222.5
Jakarta 6,249.2 +15.8
Nikkei 225 23,795.4 -235.9
SSE Comp 2,976.5 -84.2
Shanghai A 3,118.9 -88.2
Shanghai B 248.6 -8.9
PSE Comp 0.0
KOSPI 2,246.1 -21.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

PROTHENA CORP PLC PROTHENA CORP PLC
Updated on 22 Jan 2020 (End of trading day)
Last (USD): 13.920 Change: +0.280 High: 14.100 Remarks: -
Change (%): +2.05 Low: 13.690
Open 13.700 Yesterday's Close 13.64
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 101,725 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -3.90117 Trailing EPS (USD) e -1.96967 NAV (USD) b 7.2480
PE a - Trailing PE f - Price / NAV b 1.9205
Dividend (USD) d - Cash In Hand (USD) g 9.7828 Issued & Paid-up Shares c 39,897,000
Dividend Yield (%) d - Price / Cash In Hand g 1.423 Treasury Shares h -
Beta - 75 Daysi 1.910 R-Squared - 75 Days(%)i 1.84 Market Cap (M) 555.366
Beta - 500 Daysi 0.044 R-Squared - 500 Days (%)i 0.01 Enterprise Value (M) 189.225
Piotroski F Score 2 Exchange Code PRTA Par Value ( $ ) n.a.
52 Weeks Volatility (%) 54.89 Free Float (%) 100.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PROTHENA CORP PLC NASDAQ 555.366 - - 1.9205 -
Industry Biotechnology NASDAQ 2,401.036 380.284 92.382 5.9820 0.736
Local Peer AMGEN INC NASDAQ 140,673.062 16.759 17.438 12.8739 2.363
Local Peer GILEAD SCIENCES INC NASDAQ 80,248.465 14.711 29.799 3.8948 3.642
Local Peer VERTEX PHARMACEUTICAL NASDAQ 60,329.961 28.778 28.142 11.4840 -
Local Peer BIOGEN INC NASDAQ 51,985.340 11.733 9.635 3.7143 -
Local Peer ILLUMINA INC NASDAQ 48,657.000 58.907 50.007 10.9612 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 39,432.125 16.132 18.390 3.7539 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,651.817 317.678 16.767 2.3779 -
Local Peer SEATTLE GENETICS INC NASDAQ 19,143.816 - - 10.7573 -
Local Peer INCYTE CORPORATION NASDAQ 16,904.357 154.388 41.743 6.9780 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 15,733.354 - - 5.1175 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 15,229.078 - 49.069 5.5099 -
Local Peer EXACT SCIENCES CORP NASDAQ 13,981.151 - - 18.6845 -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), 10X GENOMICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), MODERNA INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), REPLIGEN CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), FIBROGEN INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), KODIAK SCIENCES INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), INSMED INC (NASDAQ), VIELA BIO INC (NASDAQ), REGENXBIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ALECTOR INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), CORTEXYME INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), TG THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NEXTCURE INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), XBIOTECH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CYTOKINETICS INC (NASDAQ), OMEROS CORP (NASDAQ), AVROBIO INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), NANTKWEST INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), RETROPHIN INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ARDELYX INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MORPHIC HOLDING INC (NASDAQ), MACROGENICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), AGENUS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), MERUS B V (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ANAPTYSBIO INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), COMPUGEN (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PERSONALIS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), GERON CORP (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), KAMADA (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), XOMA CORP (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), IMV INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CONTRAFECT CORP (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SAVARA INC (NASDAQ), VERASTEM INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), OTONOMY INC (NASDAQ), COHBAR INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), ORGENESIS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), VERMILLION INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), EQUILLIUM INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CURIS INC (NASDAQ), INMUNE BIO INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), RESTORBIO INC (NASDAQ), ADVAXIS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), EVOGENE LTD (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VAXART INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), PRECIPIO INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), BIOCEPT INC (NASDAQ), TOCAGEN INC (NASDAQ), TROVAGENE INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), OPGEN INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SPHERIX INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 139,428.012 51.969 51.969 18.6323 0.864
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,956.794 88.471 26.103 5.8881 0.678
Global Peer SINO BIOPHARM HKEx 144,849.829 13.518 14.030 4.3138 0.635
Global Peer WUXI BIO HKEx 131,263.877 175.744 137.391 13.5119 -
Global Peer BEIGENE HKEx 101,672.550 - - 10.1444 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 32,753.258 196.970 - 9.2365 -
Global Peer 3SBIO HKEx 27,533.275 18.201 22.153 2.7137 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 3,016.907 48.117 701.606 2.9149 -
Other Global Peers ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), MESOBLAST LTD (ASX), CKLIFE SCIENCES (HKEx), AVITA MEDICAL LTD (ASX), VIVA BIOTECH (HKEx), KADMON HLDGS INC (NYSE), ASCENTAGE-B (HKEx), SINOMAB BIO-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), NEXT SCIENCE LTD (ASX), DPHARMA (Bursa), PFENEX INC (NYSE American), TELIX PHARMACEUTIC (ASX), NANOVIRICIDES INC (NYSE American), BBI LIFE SCI (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), RESAPP HEALTH LIMITED (ASX), PYC THERAPEUTICS LIMITED (ASX), CEL-SCI CORP (NYSE American), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), LINEAGE CELL THERAPEUTICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), IMMUTEP LTD (ASX), ONCOSIL MEDICAL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), ORTHOCELL LIMITED (ASX), CT ENTERPRISE (HKEx), ISORAY INC (NYSE American), BIOTRON (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOSINO BIO-TEC (HKEx), ACTINOGEN MEDICAL LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), REGENT PACIFIC (HKEx), BIONOMICS LTD (ASX), MEMPHASYS LTD (ASX), TALI DIGITAL LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), IBIO INC (NYSE American), ORAGENICS INC (NYSE American), EXTRAWELL PHAR (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), RHINOMED LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), PATRYS LIMITED (ASX), CELLMID LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), Suntar Eco-City^ (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), ADALTA LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), BENITEC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), BIOXYNE LIMITED (ASX), MEDIBIO LIMITED (ASX), QT Vascular (SGX), MGRC (Bursa), TBG DIAGNOSTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.460
-9.49 %
10 Days --1.850
-11.73 %
20 Days --2.790
-16.70 %
Medium Term Return 3 Months -+5.360
+62.62 %
6 Months -+4.200
+43.21 %
1 Year -+2.500
+21.89 %
Long Term Return 2 Years --30.130
-68.40 %
3 Years --33.470
-70.63 %
5 Years --8.830
-38.81 %
Annualised Return Annualised --
-9.36 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.710 - 17.630 Change From 1 Year Low +7.210 % Change From 1 Year Low (%) +107.45
Change From 1 Year High -3.710 % Change From 1 Year High (%) -21.04
2 Years Range 6.710 - 46.140 Change From 2 Years Low +7.210 % Change From 2 Years Low (%) +107.45
Change From 2 Years High -32.220 % Change From 2 Years High (%) -69.83
5 Years Range 6.710 - 76.420 Change From 5 Years Low +7.210 % Change From 5 Years Low (%) +107.45
Change From 5 Years High -62.500 % Change From 5 Years High (%) -81.78
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Prothena Corp. Plc is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

Historical Price Data

Date Open High Low Close Volume VWAP
22 Jan 2020 13.700 14.100 13.690 13.920 101,725 -
21 Jan 2020 14.210 14.260 13.520 13.640 170,711 -
17 Jan 2020 15.540 15.700 14.170 14.260 207,812 -
16 Jan 2020 15.440 15.790 15.320 15.380 170,647 -
15 Jan 2020 15.450 15.900 14.990 15.230 163,391 -
14 Jan 2020 14.360 15.550 14.360 15.460 213,311 -
13 Jan 2020 15.320 15.392 14.310 14.460 180,875 -
10 Jan 2020 15.820 16.050 15.270 15.360 207,101 -
09 Jan 2020 15.470 15.840 15.160 15.770 180,612 -
08 Jan 2020 15.460 15.760 15.240 15.380 184,829 -
07 Jan 2020 15.200 15.970 14.840 15.500 191,290 -
06 Jan 2020 14.810 15.190 14.355 15.160 207,103 -
03 Jan 2020 15.310 15.490 14.780 14.960 120,629 -
02 Jan 2020 15.970 15.970 15.041 15.630 118,746 -
31 Dec 2019 15.650 16.170 15.650 15.830 144,486 -
30 Dec 2019 15.950 16.119 15.560 15.770 206,169 -
27 Dec 2019 16.850 16.850 15.800 16.000 223,384 -
26 Dec 2019 16.250 17.290 16.060 16.710 237,104 -
24 Dec 2019 17.010 17.010 15.640 16.210 295,490 -
23 Dec 2019 16.010 17.630 15.730 17.010 567,737 -
20 Dec 2019 13.360 16.755 13.300 15.850 1,909,302 -
19 Dec 2019 12.830 13.030 12.705 12.830 115,388 -
Summary
Current 2 Weeks
(08 Jan 2020 to 22 Jan 2020)		 15.460 16.050 13.520 13.920 1,781,014 -
Previous 2 Weeks
(23 Dec 2019 to 07 Jan 2020)		 16.010 17.630 13.520 15.500 2,312,138 -
4 Weeks from
(22 Nov 2019 to 20 Dec 2019)		 11.250 16.050 10.650 15.850 6,039,166 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.